Derive insights from population-level genomics
Better understand the dynamics of pathways and intricate biomarkers such as androgen receptor activity, DNA repair, immune profiling or chemotherapy response activation.
Reveal new biomarkers through comprehensive genomic profiling
We can profile your cohorts using the whole-transcriptome platform in our CLIA-certified, CAP-accredited, NYS-approved laboratory. With this service, you also gain access to the full repertoire of signatures from the GRID.
Enable clinical trials in earlier patient populations
Utilize more than 500 genomic signatures and 110,000 profiles in the GRID database to identify new niche populations for clinical trial design.
Commercialize your therapies faster
Screen and identify patients efficiently for clinical trial enrollment through our prospective profiling of hundreds of patients per week.